28 May 2020 --- Human milk oligosaccharides (HMOs) may inhibit the binding of noroviruses to human receptors, according to recent results from Jennewein Biotechnology’s norovirus research program. Published in the Journal of Biotechnology, the study found that certain HMOs and more complex oligosaccharides were more effective than those previously studied. Researchers note that these findings could pave the way for the use of HMOs as a potential inhibitor against infectious diseases, such as the norovirus, for which there is no vaccine.
